Get the Stockscreener App
27.52
3.27%
-0.93
After Hours:
27.39
-0.13
-0.47%
Inhibrx Biosciences Inc stock is traded at $27.52, with a volume of 111.55K.
It is down -3.27% in the last 24 hours and up +25.55% over the past month.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.
See More
Previous Close:
$28.45
Open:
$28.4
24h Volume:
111.55K
Relative Volume:
0.99
Market Cap:
$398.64M
Revenue:
$1.80M
Net Income/Loss:
$1.76B
P/E Ratio:
0.2319
EPS:
118.674
Net Cash Flow:
$-149.23M
1W Performance:
-2.34%
1M Performance:
+25.55%
6M Performance:
+87.59%
1Y Performance:
+82.49%
1-Day Range:
$27.07
$28.86
1-Week Range:
$27.07
$30.23
52-Week Range:
$10.80
$30.23
Inhibrx Biosciences Inc Stock (INBX) Company Profile
Name
Inhibrx Biosciences Inc
Sector
Industry
Phone
(858) 795-4220
Address
11025 N. TORREY PINES ROAD, SUITE 140, LA JOLLA
Compare INBX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
INBX
Inhibrx Biosciences Inc
|
27.52 | 400.52M | 1.80M | 1.76B | -149.23M | 118.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Inhibrx Biosciences Inc Stock (INBX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-23-24 | Initiated | JMP Securities | Mkt Perform |
| Jan-23-24 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| Mar-16-22 | Initiated | SMBC Nikko | Outperform |
| Sep-21-21 | Initiated | JMP Securities | Mkt Outperform |
| Apr-26-21 | Resumed | Credit Suisse | Outperform |
| Sep-14-20 | Initiated | Credit Suisse | Outperform |
| Sep-14-20 | Initiated | Evercore ISI | Outperform |
View All
Inhibrx Biosciences Inc Stock (INBX) Latest News
Applying big data sentiment scoring on Inhibrx Biosciences Inc.Exit Point & Fast Exit and Entry Trade Guides - Newser
Is Inhibrx Biosciences Inc. meeting your algorithmic filter criteriaWeekly Trend Summary & Community Shared Stock Ideas - Newser
Using data models to predict Inhibrx Biosciences Inc. stock movementEarnings Recap Summary & Safe Investment Capital Preservation Plans - Newser
What momentum shifts mean for Inhibrx Biosciences Inc.Layoff News & Long-Term Growth Stock Strategies - Newser
Ranking Inhibrx Biosciences Inc. among high performing stocks via toolsStop Loss & Low Drawdown Investment Strategies - Newser
Does Inhibrx Biosciences Inc. show high probability of reboundPortfolio Performance Report & Long-Term Investment Growth Plans - Newser
Inhibrx Biosciences Inc. stock trend outlook and recovery pathQuarterly Portfolio Summary & Weekly High Potential Alerts - Newser
How to integrate Inhibrx Biosciences Inc. into portfolio analysis toolsPortfolio Return Summary & Fast Gaining Stock Strategy Reports - Newser
Sector ETF performance correlation with Inhibrx Biosciences Inc.2025 Bull vs Bear & Free Long-Term Investment Growth Plans - Newser
Inhibrx Biosciences Inc. stock outlook for YEAR2025 Major Catalysts & Fast Gain Swing Trade Alerts - Newser
Will Inhibrx Biosciences Inc. continue its uptrendGap Up & Reliable Entry Point Trade Alerts - Newser
Trend analysis for Inhibrx Biosciences Inc. this week2025 Technical Overview & Safe Capital Growth Tips - Newser
Bluefin Capital Management LLC Acquires New Stake in Inhibrx Biosciences, Inc. $INBX - MarketBeat
How moving averages guide Inhibrx Biosciences Inc. tradingNew Guidance & Safe Entry Momentum Tips - Newser
Can Inhibrx Biosciences Inc. recover in the next quarter2025 Price Momentum & Verified Swing Trading Watchlists - Newser
Should you hold or exit Inhibrx Biosciences Inc. nowJuly 2025 Closing Moves & Daily Profit Maximizing Trade Tips - Newser
Chart based exit strategy for Inhibrx Biosciences Inc.Quarterly Investment Review & Real-Time Market Sentiment Alerts - Newser
What indicators show strength in Inhibrx Biosciences Inc.Portfolio Growth Summary & Weekly Top Gainers Alerts - Newser
What MACD signals say about Inhibrx Biosciences Inc.Quarterly Trade Summary & Risk Managed Investment Signals - Newser
What recovery options are there for Inhibrx Biosciences Inc.2025 Market Overview & Safe Entry Momentum Stock Tips - Newser
Will Inhibrx Biosciences Inc. price bounce be sustainable2025 Pullback Review & Daily Stock Trend Reports - Newser
What the charts say about Inhibrx Biosciences Inc. todayBuy Signal & Accurate Entry/Exit Alerts - Newser
What candlestick patterns are forming on Inhibrx Biosciences Inc.July 2025 Gainers & Verified Technical Signals - Newser
Analyzing drawdowns of Inhibrx Biosciences Inc. with statistical tools2025 Price Momentum & Risk Managed Trade Strategies - Newser
Is Inhibrx Biosciences Inc. still worth holding after the dipQuarterly Portfolio Report & Target Return Focused Picks - Newser
Slotnik Capital LLC Lowers Stock Position in Inhibrx Biosciences, Inc. $INBX - MarketBeat
Tools to monitor Inhibrx Biosciences Inc. recovery probability2025 Market Trends & Low Drawdown Trading Techniques - Newser
State of Wyoming Has $40,000 Stock Holdings in Inhibrx Biosciences, Inc. $INBX - Defense World
Key resistance and support levels for Inhibrx Biosciences Inc.2025 Performance Recap & Real-Time Volume Analysis - Newser
Nuveen LLC Invests $350,000 in Inhibrx Biosciences, Inc. $INBX - MarketBeat
Is this a good reentry point in Inhibrx Biosciences Inc.Market Risk Analysis & Free Fast Gain Swing Trade Alerts - Newser
How to forecast Inhibrx Biosciences Inc. trends using time seriesGap Up & Risk Adjusted Swing Trade Ideas - Newser
Inhibrx Biosciences Inc. stock momentum explainedJuly 2025 Earnings & Precise Buy Zone Identification - Newser
Volatility clustering patterns for Inhibrx Biosciences Inc.2025 Investor Takeaways & Expert Verified Movement Alerts - Newser
Inhibrx Biosciences Inc Stock (INBX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):